Eyal Rubin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Eyal Rubin
Earlier roles on record: CFO at Protalix BioTherapeutics, Inc. (PLX) until July 21, 2025. Protalix BioTherapeutics, Inc. reported in an 8-K filed July 21, 2025 that Eyal Rubin resigned as Vice President and Chief Financial Officer. Protalix BioTherapeutics, Inc. reported in an 8-K filed April 23, 2025 that Eyal Rubin resigned as Sr. Vice President and Chief Financial Officer. The proxy statement of Protalix BioTherapeutics, Inc. reports total compensation of $1,029,035 for Eyal Rubin in fiscal 2023, including a base salary of $287,692. Disclosed compensation is on record for 4 fiscal years. Eyal Rubin has spoken on 21 earnings calls across 1 company, most recently for Protalix BioTherapeutics, Inc. on August 14, 2025.
“As announced on April 21, 2025, Eyal Rubin has notified the Company of his resignation from his position as the Company's Vice President and Chief Financial Officer to pursue other opportunities.”
“On April 21, 2025, Eyal Rubin, Sr. Vice President and Chief Financial Officer of Protalix BioTherapeutics, Inc., a Delaware corporation (the "Company"), provided the Company and the Company's Board of Directors with six months' notice of his resignation from his position with the Company and its subsidiary, in order to pursue other opportunities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-07-21
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2023 | Protalix BioTherapeutics, Inc. (PLX) | Senior Vice President and Chief Financial Officer | $287,692 | $1,029,035 |
| 2022 | Protalix BioTherapeutics, Inc. (PLX) | Senior Vice President and Chief Financial Officer | $312,515 | $1,058,281 |
| 2021 | Protalix BioTherapeutics, Inc. (PLX) | Senior Vice President, Chief Financial Officer | $325,101 | $836,824 |
| 2020 | Protalix BioTherapeutics, Inc. (PLX) | Senior Vice President, Chief Financial Officer | $303,540 | $920,099 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.